Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

While typically low-risk, cutaneous squamous cell carcinoma (cSCC) can infrequently progress to metastatic disease with in-transit lesions, localized to the dermis or subcutaneous tissue between the primary tumor and draining regional lymph nodes. These lesions are associated with poor prognostic va...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dina Poplausky, Jade N. Young, Brandon R. Block, Yeriel Estrada, Giselle K. Singer, Vicky Wong, Patricia Cabral, Yamato Suemitsu, Randie H. Kim, Philip Friedlander, Nicholas Gulati
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-05-01
Series:	Frontiers in Oncology
Assuntos:	cutaneous metastases metastatic squamous cell carcinoma diphencyprone (DCP DPCP) immune check inhibitor (ICI) open-label clinical study
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1294331/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!